Related Experiment Video
Updated: Jul 29, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Revascularization in advanced stable coronary artery disease
1Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA.
Drugs of Today (Barcelona, Spain : 1998)
|April 20, 2004
Summary
Clinicians can use survival data to guide revascularization decisions for stable coronary artery disease (CAD). Advanced CAD with left ventricular dysfunction or ischemia favors aggressive treatment like coronary artery bypass grafting (CABG).
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Identifying stable coronary artery disease (CAD) patients who benefit from revascularization is clinically challenging.
- Current treatment strategies require refinement for optimal patient outcomes in advanced CAD.
Purpose of the Study:
- To develop a clinical guide for revascularization decisions in advanced stable CAD based on survival data.
- To differentiate patients who benefit from aggressive revascularization versus medical therapy alone.
Main Methods:
- Analysis of survival data to establish criteria for revascularization.
- Evaluation of factors including advanced CAD, left ventricular (LV) dysfunction, and significant ischemia.
- Comparison of outcomes for coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA).
Main Results:
- Survival data support CABG recommendation with at least two factors: advanced CAD, LV dysfunction, and significant ischemia.
- CABG is the preferred treatment for advanced CAD with LV dysfunction or left main coronary artery disease.
- For advanced CAD with normal LV function but significant ischemia, CABG and PTCA offer similar survival; PTCA has higher repeat revascularization rates.
Conclusions:
- A survival data-driven approach aids revascularization decisions in advanced stable CAD.
- Patient-specific factors and preferences influence the choice between CABG and PTCA when survival outcomes are similar.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...